Extracellular matrix regulation of growth factor and protease activity.

[1]  J. Gabrilove,et al.  Phospholipase C release of basic fibroblast growth factor from human bone marrow cultures as a biologically active complex with a phosphatidylinositol-anchored heparan sulfate proteoglycan , 1991, The Journal of cell biology.

[2]  S. Pizzo,et al.  The inhibition of tissue type plasminogen activator by plasminogen activator inhibitor-1. The effects of fibrinogen, heparin, vitronectin, and lipoprotein(a). , 1991, Journal of Biological Chemistry.

[3]  K. Sakaguchi,et al.  Identification of heparan sulfate proteoglycan as a high affinity receptor for acidic fibroblast growth factor (aFGF) in a parathyroid cell line. , 1991, Journal of Biological Chemistry.

[4]  Y. Kita,et al.  Role of glycosaminoglycans in the regulation of T cell proliferation induced by thymic stroma-derived T cell growth factor. , 1991, Journal of Immunology.

[5]  M. Klagsbrun,et al.  A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF , 1991, Science.

[6]  Jeffrey D. Esko,et al.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor , 1991, Cell.

[7]  S. Vukicevic,et al.  Transforming growth factor beta type 1 binds to collagen IV of basement membrane matrix: implications for development. , 1991, Developmental biology.

[8]  N. Yamamoto,et al.  Sequestration of a hepatocyte growth factor in extracellular matrix in normal adult rat liver. , 1991, Biochemical and biophysical research communications.

[9]  C. Cordon-Cardo,et al.  Expression of basic fibroblast growth factor in normal human tissues. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[10]  M. Abe,et al.  Platelet factor 4 blocks the binding of basic fibroblast growth factor to the receptor and inhibits the spontaneous migration of vascular endothelial cells. , 1990, Biochemical and biophysical research communications.

[11]  M. Jaye,et al.  Effect of heparin on the binding affinity of acidic FGF for the cloned human FGF receptors, flg and bek. , 1990, Biochemical and biophysical research communications.

[12]  D. Rifkin,et al.  Heparin and heparan sulfate increase the radius of diffusion and action of basic fibroblast growth factor , 1990, The Journal of cell biology.

[13]  M. Raff,et al.  Extracellular matrix-associated molecules collaborate with ciliary neurotrophic factor to induce type-2 astrocyte development , 1990, The Journal of cell biology.

[14]  E. Ruoslahti,et al.  Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. , 1990, The Journal of clinical investigation.

[15]  D. Rifkin,et al.  Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self- regulating system , 1990, The Journal of cell biology.

[16]  E. Ruoslahti,et al.  Negative regulation of transforming growth factor-β by the proteoglycan decorin , 1990, Nature.

[17]  R. Silverstein,et al.  Thrombospondin forms complexes with single-chain and two-chain forms of urokinase. , 1990, The Journal of biological chemistry.

[18]  S. Pizzo,et al.  Kinetic analysis of the effects of heparin and lipoproteins on tissue plasminogen activator mediated plasminogen activation. , 1990, Biochemistry.

[19]  S. Pizzo,et al.  Regulation of plasminogen activation by components of the extracellular matrix. , 1990, Biochemistry.

[20]  A. Brown,et al.  The proto‐oncogene int‐1 encodes a secreted protein associated with the extracellular matrix. , 1990, The EMBO journal.

[21]  T. Nakamura,et al.  Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Sanderson,et al.  Syndecan, a developmentally regulated cell surface proteoglycan that binds extracellular matrix and growth factors. , 1990, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[23]  A. Baird,et al.  Distribution of basic fibroblast growth factor in the 18-day rat fetus: localization in the basement membranes of diverse tissues , 1990, The Journal of cell biology.

[24]  D. Rifkin,et al.  Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. , 1990 .

[25]  J. Massagué,et al.  Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta , 1989, The Journal of cell biology.

[26]  J. Weatherbee,et al.  Transforming growth factor‐β1 binds to immobilized fibronectin , 1989 .

[27]  J. D. Bradley,et al.  Differential effects of heparin, fibronectin, and laminin on the phosphorylation of basic fibroblast growth factor by protein kinase C and the catalytic subunit of protein kinase A , 1989, The Journal of cell biology.

[28]  R. Bar-Shavit,et al.  Binding of thrombin to subendothelial extracellular matrix. Protection and expression of functional properties. , 1989, The Journal of clinical investigation.

[29]  G. Conn,et al.  Extracellular matrix heparan sulfate proteoglycans modulate the mitogenic capacity of acidic fibroblast growth factor , 1989, Journal of cellular physiology.

[30]  J. Massagué,et al.  Transforming growth factor-beta (TGF-beta) receptor proteoglycan. Cell surface expression and ligand binding in the absence of glycosaminoglycan chains. , 1989, The Journal of biological chemistry.

[31]  M. Rusnati,et al.  Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form , 1989, Journal of cellular physiology.

[32]  D. Rifkin,et al.  Recent developments in the cell biology of basic fibroblast growth factor , 1989, The Journal of cell biology.

[33]  D. Rifkin,et al.  Role of extracellular matrix in the action of basic fibroblast growth factor: Matrix as a source of growth factor for long‐term stimulation of plasminogen activator production and DNA synthesis , 1989, Journal of cellular physiology.

[34]  D. Rifkin,et al.  Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture , 1989, The Journal of cell biology.

[35]  Sandra R. Smith,et al.  An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[36]  J. Wagner,et al.  Heparin potentiates the action of acidic fibroblast growth factor by prolonging its biological half‐life , 1989, Journal of cellular physiology.

[37]  J. Mimuro,et al.  Purification of a protein from bovine plasma that binds to type 1 plasminogen activator inhibitor and prevents its interaction with extracellular matrix. Evidence that the protein is vitronectin. , 1989, The Journal of biological chemistry.

[38]  Y. Courtois,et al.  Specific binding of basic fibroblast growth factor to basement membrane‐like structures and to purified heparan sulfate proteoglycan of the EHS tumor , 1988, Journal of cellular physiology.

[39]  M. Gordon,et al.  Hierarchical organization of hematopoietic microenvironments: role of proteoglycans. , 1988, Leukemia.

[40]  W. Anderson,et al.  Site-directed neovessel formation in vivo. , 1988, Science.

[41]  D. Rifkin,et al.  Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation , 1988, The Journal of cell biology.

[42]  P. Segarini,et al.  The high molecular weight receptor to transforming growth factor-beta contains glycosaminoglycan chains. , 1988, The Journal of biological chemistry.

[43]  R. Friesel,et al.  Heparin protects heparin-binding growth factor-I from proteolytic inactivation in vitro. , 1988, Biochemical and biophysical research communications.

[44]  T. Dexter,et al.  Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis , 1988, Nature.

[45]  V. Ferrans,et al.  Heparin-binding growth factor-I (endothelial cell growth factor) binds to endothelium in vivo. , 1988, Journal of vascular surgery.

[46]  D. Ingber,et al.  A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane. , 1988, The American journal of pathology.

[47]  Y. Courtois,et al.  Specific fixation of bovine brain and retinal acidic and basic fibroblast growth factors to mouse embryonic eye basement membranes. , 1987, Experimental cell research.

[48]  D. Moscatelli,et al.  High and low affinity binding sites for basic fibroblast growth factor on cultured cells: Absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells , 1987, Journal of cellular physiology.

[49]  J. Massagué,et al.  The transforming growth factor-β system, a complex pattern of cross-reactive ligands and receptors , 1987, Cell.

[50]  D. Gospodarowicz,et al.  Heparin protects basic and acidic FGF from inactivation , 1986, Journal of cellular physiology.

[51]  R. Silverstein,et al.  Binding of plasminogen to extracellular matrix. , 1986, The Journal of biological chemistry.

[52]  J. Zeuthen,et al.  Plasminogen and tissue-type plasminogen activator bind to immobilized fibronectin. , 1985, The Journal of biological chemistry.

[53]  J. Kenney,et al.  Interaction of endothelial cell growth factor with heparin: characterization by receptor and antibody recognition. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[54]  D. Gospodarowicz,et al.  Isolation of brain fibroblast growth factor by heparin-Sepharose affinity chromatography: identity with pituitary fibroblast growth factor. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[55]  A. Schreiber,et al.  Heparin binds endothelial cell growth factor, the principal endothelial cell mitogen in bovine brain. , 1984, Science.

[56]  J. Folkman,et al.  Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. , 1984, Science.

[57]  E. Levine,et al.  Human endothelial cells: use of heparin in cloning and long-term serial cultivation. , 1983, Science.

[58]  T. Maciag,et al.  The heparin-binding (fibroblast) growth factor family of proteins. , 1989, Annual review of biochemistry.

[59]  J. Massagué,et al.  Transforming growth factor-beta inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor. , 1989, The Journal of biological chemistry.

[60]  P. Hauschka,et al.  Polypeptide growth factors in bone matrix. , 1988, Ciba Foundation symposium.

[61]  K. Preissner.  Anticoagulant potential of endothelial cell membrane components. , 1988, Haemostasis.

[62]  M. Greaves,et al.  Compartmentalization of a haematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment , 1987, Nature.